Cardiology Insight Digest

AI Advances in Cardiac Imaging and Precision Medicine

• 🔥 Multiview DNN for Imaging: Researchers developed a new multiview deep neural network...

Emerging AI trend reshaping CV practice:

• Autonomous care advances: CV med enters new phase with first-ever U.S. gov funding for autonomous...

Pacemakers at risk:

• St. Jude Medical implantable cardiac devices have multiple vulnerabilities hackers could exploit to harm patients.
• Reveals...

Dyslipidemia Guideline Updates

• 🔥 ACC/AHA Recommendations: ACC/AHA and other associations issued updated guidelines recommending earlier...

Fresh ACC/AHA dyslipidemia guidelines emphasize updated management strategies, timed perfectly with enlicitide's phase 3 success:

• Oral PCSK9...

Fine particulate matter exposure links to increased risk of major adverse cardiac events. Air pollution elevates CVD risk among non-communicable diseases, highlighting its role as a modifiable factor for public health counseling.

Former cardiac surgeon Dr. David Luu pushes longevity medicine to redefine healthcare from sick care to prevention.

Key insights:

• AI + wearables...

Ahead of the April 25 event, here's what clinicians gain from ASPC's Multimodality Cardiovascular Imaging Symposium:

• Practical integration: Use...

Game-changer for high-risk patients: Shingles vaccine linked to 46% lower major adverse cardiac events and 66% lower all-cause mortality in 246k+...

Can the shorter KCCQ-12 replace KCCQ-23 for HFmrEF/HFpEF patients?

• New study examines their interchangeability
• Uses participant-level analysis

Key for standardizing PROs in heart failure trials and practice.

• HeartFlow AI predicts MACE, drives superior lipid outcomes, and enables cost-effective care, backed by ACC presentations
• Dynamic forecasts deliver...

Aspirin's role in primary prevention of cardiovascular disease has undergone substantial reassessment over the past decade as emerging evidence has reshaped paradigms. Death or rebirth?

Key takeaways from incoming ACC President Roxana Mehran and TIO Director Nicholas Van Mieghem:

• Sex differences in CVD: Underdiagnosis of...

Key clinic translations from new guidelines:

• Screening: Childhood start, every 5 years from age 19; FH test ages 9-11
• LDL targets: ≤100 mg/dL...

Guideline Updates

• 🔥 2026 ACC/AHA Dyslipidemia Guideline: New guidance calls for earlier risk assessment starting at age 30 for high-risk adults...

Key insights from preventive cardiologist Dr. John Osborne (29 years experience, two doctorates):

• AI revolution in screening: Cardiac CT with AI...

Key insights from Covington attorneys and Meta's compliance chief on digital health challenges:

• Global evolution: Worldwide regulatory landscape
  -...

• Multi-phase study tests rapamycin's effects in older adults, shifting from off-label use to evidence-based dosing, safety, and outcomes.
• Phase 1:...

Key insights from ICM comparisons for high-risk AF detection:

• REVEAL AF revealed high incidence of undiagnosed AF in high-risk patients using...

Pre-ACC 2026 buzz highlights major shifts in lipid management:

• Earlier intervention from age 30 using PREVENT equations for 10-30 year risk, with...